Your browser doesn't support javascript.
loading
Most viral peptides displayed by class I MHC on infected cells are immunogenic.
Croft, Nathan P; Smith, Stewart A; Pickering, Jana; Sidney, John; Peters, Bjoern; Faridi, Pouya; Witney, Matthew J; Sebastian, Prince; Flesch, Inge E A; Heading, Sally L; Sette, Alessandro; La Gruta, Nicole L; Purcell, Anthony W; Tscharke, David C.
Afiliação
  • Croft NP; Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; nathan.croft@monash.edu anthony.purcell@monash.edu david.tscharke@anu.edu.au.
  • Smith SA; Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia.
  • Pickering J; John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.
  • Sidney J; John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.
  • Peters B; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.
  • Faridi P; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.
  • Witney MJ; Department of Medicine, University of California, San Diego, La Jolla, CA 92093.
  • Sebastian P; Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • Flesch IEA; Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia.
  • Heading SL; John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.
  • Sette A; John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.
  • La Gruta NL; John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.
  • Purcell AW; John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.
  • Tscharke DC; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.
Proc Natl Acad Sci U S A ; 116(8): 3112-3117, 2019 02 19.
Article em En | MEDLINE | ID: mdl-30718433
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Peptídeos / Antígenos de Histocompatibilidade Classe I / Linfócitos T CD8-Positivos / Formação de Anticorpos Limite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Peptídeos / Antígenos de Histocompatibilidade Classe I / Linfócitos T CD8-Positivos / Formação de Anticorpos Limite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2019 Tipo de documento: Article